A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia

<p>Abstract</p> <p>Background</p> <p>Cognitive deficits in schizophrenia are associated with psychosocial deficits that are primarily responsible for the poor long-term outcome of this disease. Auditory sensory gating P50 deficits are correlated with neuropsychological...

Full description

Bibliographic Details
Main Authors: Shiraishi Tetsuya, Kanahara Nobuhisa, Haraguchi Tadashi, Hasegawa Tadashi, Yoshida Taisuke, Hashimoto Tasuku, Niitsu Tomihisa, Shirayama Yukihiko, Shiina Akihiro, Fujisaki Mihisa, Fukami Goro, Nakazato Michiko, Iyo Masaomi, Hashimoto Kenji
Format: Article
Language:English
Published: BMC 2010-06-01
Series:Annals of General Psychiatry
Online Access:http://www.annals-general-psychiatry.com/content/9/1/27

Internet

http://www.annals-general-psychiatry.com/content/9/1/27

Similar Items